Nonvisualization of the Endolymphatic Duct, Sac Common in Meniere Disease
THURSDAY, Oct. 5, 2023 (HealthDay News) — Nonvisualization of the endolymphatic duct (ED) and sac (ES) system is significantly associated with Meniere disease (MD), according to a study published online Aug. 31 in Frontiers in Neurology.Lisa M.H. de …
Learn MoreSarcopenia Worsens Liver Transplant Outcomes for Patients With Cirrhosis
THURSDAY, Oct. 5, 2023 (HealthDay News) — Sarcopenia is associated with adverse outcomes after liver transplantation (LT) in patients with decompensated cirrhosis (DC), according to a study published online Sept. 21 in the Journal of Cachexia, Sarcop…
Learn MoreSarcopenia Worsens Liver Transplant Outcomes for Patients With Cirrhosis
THURSDAY, Oct. 5, 2023 (HealthDay News) — Sarcopenia is associated with adverse outcomes after liver transplantation (LT) in patients with decompensated cirrhosis (DC), according to a study published online Sept. 21 in the Journal of Cachexia, Sarcop…
Learn MoreEarly Metformin May Not Aid Gestational Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Early metformin initiation in women with gestational diabetes does not reduce the occurrence of the combination of a fasting glucose level ≥5.1 mmol/L at gestation weeks 32 or 38 or insulin initiation, accord…
Learn MoreEarly Metformin May Not Aid Gestational Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Early metformin initiation in women with gestational diabetes does not reduce the occurrence of the combination of a fasting glucose level ≥5.1 mmol/L at gestation weeks 32 or 38 or insulin initiation, accord…
Learn MoreTirzepatide Bests Semaglutide for Patients With Type 2 Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European Association for the Study of Diabetes Ann…
Learn MoreTirzepatide Bests Semaglutide for Patients With Type 2 Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European Association for the Study of Diabetes Ann…
Learn MoreFDA Approves Updated Novavax COVID-19 Vaccine
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Federal regulators on Tuesday gave the go-ahead to an updated Novavax COVID-19 vaccine, giving Americans a more traditional alternative to two recently revamped mRNA vaccines.Adolescents and adults who have …
Learn MoreMore Than 75,000 Kaiser Permanente Union Workers Go on Strike
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Health care workers who serve millions of Americans began a three-day strike on Wednesday after contract negotiations over staffing levels stalled.More than 75,000 members of the Coalition of Kaiser Permanen…
Learn MoreMachine Learning Can Better ID Who Needs Lung Cancer Screening
TUESDAY, Oct. 3, 2023 (HealthDay News) — A machine learning model that uses only data on age, smoking duration, and pack-years can predict lung cancer risk and identify who needs lung cancer screening with better performance than currently used metho…
Learn More